• Protein A/G Magnetic Beads for Cell Assays

  2026-08-24

  Learn how Protein A/G Magnetic Beads, SKU K1305, can strengthen the mechanistic arm of cell viability, proliferation, and cytotoxicity studies without being mistaken for a direct viability reagent. This scenario-based guide covers assay design, immunoprecipitation controls, protocol parameters, data interpretation, and practical supplier selection.

• Novobiocin Susceptibility in Resistant Staphylococci

  2026-08-23

  This 2010 veterinary dermatology study compared mupirocin and Novobiocin activity against methicillin-susceptible and methicillin-resistant staphylococci from healthy dogs and dogs with superficial pyoderma. Its main practical contribution is showing that Novobiocin retained substantial in vitro activity against resistant isolates, although susceptibility varied by clinical population and did not establish clinical efficacy.

• InstaBlue Protein Stain Solution for tiRNA Studies

  2026-08-22

  InstaBlue Protein Stain Solution provides a rapid Coomassie Brilliant Blue protein stain workflow for connecting translation-inhibition experiments with protein-level evidence. This article explains how to interpret gel signals, design controls, and avoid confusing visualization with quantitative or mechanistic proof.

• Trichostatin A (TSA): Designing Better Epigenetic Assays

  2026-08-21

  Trichostatin A (TSA) is more than a broad HDAC inhibitor: it can serve as a reversible probe for distinguishing chromatin-mediated silencing from sequence-level failure. This guide connects TSA mechanism, assay controls, and synthetic-biology applications to improve cancer and epigenetic research workflows.

• Redox Strategy for L-Glutathione Reduced

  2026-08-20

  A translational framework for using L-Glutathione Reduced to interrogate redox vulnerability, validate GOT1-linked metabolic phenotypes, and improve reproducibility in cancer and GST workflows.

• AG-221 (Enasidenib) in IDH2-Mutant AML Research

  2026-08-20

  AG-221 (Enasidenib) provides a practical way to connect mutant-IDH2 inhibition with 2-hydroxyglutarate reduction, leukemia cell differentiation, and metabolic dependency assays. This workflow combines genotype confirmation, metabolite quantification, phenotypic profiling, and CD44-focused combination experiments for more informative acute myeloid leukemia research.

• GR-Mediated Hippocampal CYP Suppression by PCN

  2026-08-19

  This 2025 study shows that pregnenolone 16α-carbonitrile suppresses hippocampal CYP3A11 and CYP2B10 expression while inducing these enzymes in the liver. Its central innovation is the identification of glucocorticoid receptor signaling, rather than PXR, as the mediator of hippocampal protection against phenytoin-associated neurotoxicity.

• CEP in Nasopharyngeal Carcinoma: Mechanistic Study

  2026-08-19

  A 2024 Journal of Ethnopharmacology study combined network pharmacology, molecular docking, cell assays, pathway analysis, and a nude-mouse xenograft model to investigate cepharanthine (CEP) in nasopharyngeal carcinoma. Its findings connect CEP activity with suppression of the EGFR/PI3K/AKT/mTOR axis, while also defining important limitations for interpreting computational target predictions as pharmacological mechanisms.

• Trichostatin A (TSA) in Cancer Research

  2026-08-18

  Trichostatin A (TSA) provides reversible HDAC inhibition for linking histone acetylation to proliferation, differentiation, and cancer-cell fate. This workflow also shows how TSA can complement mitochondrial calcium and ferroptosis studies without being mistaken for a selective MCU or GPX4 probe.

• 8-Chloroadenosine for RNA Workflow Design

  2026-08-18

  8-Chloroadenosine provides an acute chemical approach for suppressing RNA synthesis, complementing genetic knockdown and mRNA-decay assays. This workflow guide shows how to use the nucleoside analog to interrogate lncRNA–IL-6 signaling, optimize cell experiments, and distinguish transcriptional effects from transcript stability.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-17

  Protein A/G Magnetic Beads (SKU K1305) provide Fc-directed antibody capture for purification, immunoprecipitation, co-IP, and Ch-IP from complex samples. They are intended for research workflows involving serum, cell culture supernatant, ascites, or lysates, and should not be used for diagnostic or medical purposes.

• Bestatin Stimulates Endothelial Invasion in Fibrin

  2026-08-17

  The reference study revealed that Bestatin can enhance, rather than suppress, microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its dose-dependent behavior and lack of a clear CD13 or uPAR explanation demonstrate why angiogenesis findings must be interpreted within the specific extracellular-matrix and proteolytic context.

• CCK-8 for HCC Senescence and Viability Studies

  2026-08-16

  Use Cell Counting Kit-8 (CCK-8) to connect genetic perturbations with quantitative proliferation, viability, and cytotoxicity readouts in hepatocellular carcinoma models. This practical guide explains WST-8 assay setup, controls, normalization, and how to interpret metabolic signals alongside senescence markers in WWP2–CMTM6–p21 research.

• DAMGO: From MOR Agonism to Pain-Circuit Logic

  2026-08-15

  DAMGO is a selective µ-opioid receptor agonist for linking receptor activation to pain-circuit behavior. This article interprets recent brain-to-spinal findings and translates them into more rigorous assay-design decisions for opioid receptor signaling research.

• Resiniferatoxin (RTX) Workflows for TRPV1 Pain Research

  2026-08-14

  Resiniferatoxin (RTX) converts TRPV1 activation into a controllable model of calcium influx, sensory-neuron desensitization, and persistent analgesia. This workflow-focused guide shows how to use RTX in calcium imaging, peripheral pain models, and cholesterol-dependent mechanism studies while avoiding common dosing, handling, and endpoint errors.

8719 records 1/582 page Next 12345 下5页 Last page